These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32307372)

  • 1. [10. Quantitative Measurement and Quality Control in Positron Emission Tomography].
    Wagatsuma K; Sakata M; Miwa K; Miyaji N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2020; 76(4):437-443. PubMed ID: 32307372
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative positron emission tomography imaging for response assessment of [18F]fluorodeoxyglucose-avid lymphomas: should we report standard uptake value confidence limits?
    Laffon E; Marthan R
    J Clin Oncol; 2015 Apr; 33(10):1218-9. PubMed ID: 25691673
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
    Schneider DB; Clary-Macy C; Challa S; Sasse KC; Merrick SH; Hawkins R; Caputo G; Jablons D
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):128-33. PubMed ID: 10884665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
    Kwee TC; Torigian DA; Alavi A
    J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality control of PET imaging: from study to diagnosis].
    Daisaki H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167
    [No Abstract]   [Full Text] [Related]  

  • 6. F18-fluordesoxyglucose positron emission tomography-computed tomography of the kidney after calculus passage.
    Quentin M; Hautzel H; Arsov C; Scherer A
    Nephrology (Carlton); 2013 Jan; 18(1):75-6. PubMed ID: 23252806
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.
    Delbeke D; Coleman RE; Guiberteau MJ; Brown ML; Royal HD; Siegel BA; Townsend DW; Berland LL; Parker JA; Hubner K; Stabin MG; Zubal G; Kachelriess M; Cronin V; Holbrook S
    J Nucl Med; 2006 May; 47(5):885-95. PubMed ID: 16644760
    [No Abstract]   [Full Text] [Related]  

  • 8. Positron emission tomography response criteria in solid tumours criteria for quantitative analysis of [18F]-fluorodeoxyglucose positron emission tomography with integrated computed tomography for treatment response assessment in metastasised solid tumours: All that glitters is not gold.
    Willemsen AECAB; Vlenterie M; van Herpen CML; van Erp NP; van der Graaf WTA; de Geus-Oei LF; Oyen WJG
    Eur J Cancer; 2016 Mar; 56():54-58. PubMed ID: 26808297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
    Lee HJ; Kim JS; Roh JL; Lee JH; Cho KJ; Park GC; Choi SH; Nam SY; Kim SY
    Clin Otolaryngol; 2013 Feb; 38(1):30-8. PubMed ID: 23167514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fallacy of Quantifying Lymphoma Activity by Scaling to the Liver in [18F]Fluorodeoxyglucose Positron Emission Tomography (Deauville criteria).
    Keramida G; Peters AM
    J Clin Oncol; 2015 Dec; 33(34):4120-1. PubMed ID: 26304889
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of fluorodeoxyglucose positron emission tomography in women with breast cancer (Br J Surg 2005; 92: 1363-1367).
    Hayanga AJ
    Br J Surg; 2006 Feb; 93(2):252; author reply 252-3. PubMed ID: 16432827
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery.
    Cardillo A; De Cicco C; Paganelli G; Ghisini R; Peruzzotti G; Balduzzi A; Goldhirsch A; Rotmensz N; Veronesi P; Luini A; Intra M; Colleoni M
    Ann Oncol; 2007 Feb; 18(2):394-5. PubMed ID: 17043097
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules.
    Sebastianes FM; Pereira MA; Cerci JJ
    Am J Otolaryngol; 2009; 30(4):291-2; author reply 292-3. PubMed ID: 19563946
    [No Abstract]   [Full Text] [Related]  

  • 14. [Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].
    Vaylet F; Bonnichon A; Salles Y; Gontier E; Bonardel G; Lefloch H; Mairovitz A; Mantzarides M; Niang A; Marotel C; Foehrenbach H
    Cancer Radiother; 2007; 11(1-2):16-22. PubMed ID: 17137819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal thyroid uptake on 18F-fluorodeoxyglucose positron emission tomography: interpreting the data.
    Stack BC; Bodenner DL; Bartel TB; Boeckmann J
    Thyroid; 2013 May; 23(5):636-7. PubMed ID: 23281924
    [No Abstract]   [Full Text] [Related]  

  • 16. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis.
    Vaglio A; Versari A; Fraternali A; Ferrozzi F; Salvarani C; Buzio C
    Arthritis Rheum; 2005 Feb; 53(1):122-5. PubMed ID: 15696564
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and risk of malignancy of thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron-emission tomography.
    Treglia G; Giovanella L; Bertagna F; Di Franco D; Salvatori M
    Thyroid; 2013 Jan; 23(1):124-6. PubMed ID: 23289835
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
    Sharma SD; Jacques T; Smith S; Watters G
    J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent evidences of the use of 18F-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer.
    Dias AR; Nahas SC; Camargo EE; Nahas CS
    J Surg Educ; 2007; 64(2):114-9. PubMed ID: 17462214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(18)F-fluorodeoxyglucose positron emission tomography/computed tomography and unknown origin primary tumor. Current usefulness and future perspectives].
    Duch J
    Med Clin (Barc); 2013 Jan; 140(1):22-3. PubMed ID: 23122613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.